Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply

@article{Logunov2020SafetyAE,
  title={Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply},
  author={Denis Yu. Logunov and Inna V. Dolzhikova and Amir I Tukhvatullin and Dmitry V. Shcheblyakov},
  journal={Lancet (London, England)},
  year={2020},
  volume={396},
  pages={e54 - e55}
}
COVID-19-Impfungen: Replizierend oder Nichtreplizierend?
TLDR
The Gamaleya institute developed the COVID-19 vaccine named Sputnik using adenoviral vectors ad 26 and ad5 to incorporate a full SARS-Spike Protein for vaccination, which has raised controversy among small sample sizes in phase II and early endpoints in phase III studies with SpUTnik.
Pharmacovigilance of COVID-19 vaccines in the context of Nepal: an assessment based on early adverse drug reaction reports
TLDR
Assessment of the ongoing pharmacovigilance of coronavirus disease-19 (COVID-19) vaccines in the Nepalese context based on the available preliminary adverse drug reaction (ADR) reports and suggest approaches for strengthening pharmacvigilance mechanisms are suggested.
COVID-19 Vaccination Acceptance Among Chinese Population and Its Implications for the Pandemic: A National Cross-Sectional Study
TLDR
It is discovered that having no religious affiliation, having the same occupational status as a result of coronavirus epidemic, being a non-smoker, always engaging in physical activity, having a lower social status, perceiving COVID-19 to be easily curable, and having easier access to vaccination are all associated with high vaccination rate.
Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Population-based Case-control Study in St. Petersburg, Russia
TLDR
COVID-19 vaccination was effective against referral to hospital in patients with symptomatic SARS-CoV-2 infection in St. Petersburg, Russia, and a sharp increase was observed in the probability of hospital admission with age for non-vaccinated patients in relation to an almost flat relationship for the completely vaccinated group.
A review on vaccine pharmacovigilance during covid-19
TLDR
With BioNTech/Pfizer-m-RNA, Moderna-mRNA vaccine, Covishield, Johnson and Johnson, Vaxzevria, Sputnik V, Convidecia, pharmacovigilance are addressed.
Mild Adverse Events of Sputnik V Vaccine Extracted from Russian Language Telegram Posts via BERT Deep Learning Model
TLDR
The results showed that the AE profile of Sputnik V was comparable with other COVID-19 vaccines, and the sentinel properties of participatory trials could still provide meaningful information about pharmaceutics, especially if only a limited amount of information on AEs is provided by producers.
Controversy surrounding the Sputnik V vaccine
Mild Adverse Events of Sputnik V Vaccine Extracted from Russian Language Telegram Posts via BERT Deep Learning Model (Preprint)
TLDR
The revealed adverse events profile of Sputnik V is comparable with other COVID-19 vaccines and how count of administered doses, age, gender, and sequence of shots could confound reporting AEs is explored.
Mild Adverse Events of Sputnik V Vaccine in Russia: Social Media Content Analysis of Telegram via Deep Learning
TLDR
The results showed that Sputnik V AEs were more similar to other vector vaccines (132 units) than with messenger RNA vaccines (241 units) according to the average Euclidean distance between the vectors of AE frequencies.
...
1
2
...